Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. Its da Vinci surgical system include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments that include forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci Single-Site instruments and accessories that allow surgical systems to work through a single incision; and EndoWrist One vessel sealers that are wristed single-use instruments intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist stapler, a wristed stapling instrument intended for resection, transection, and/or creation of anastomoses, as well as sells various accessories, including replacement 3-D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci system, as well as sterile drapes for ensuring a sterile field during surgery. Intuitive Surgical, Inc. markets its products directly and through distributors in the United States, Europe, Asia, and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ISRG
CUSIP46120E60
Phone408-523-2100
Debt
Debt-to-Equity RatioN/A
Current Ratio5.82
Quick Ratio5.33
Price-To-Earnings
Trailing P/E Ratio67.80
Forward P/E Ratio55.14
P/E Growth4.59
Sales & Book Value
Annual Sales$3.13 billion
Price / Sales17.65
Cash Flow$8.4907 per share
Price / Cash57.41
Book Value$42.19 per share
Price / Book11.55
Profitability
EPS (Most Recent Fiscal Year)$7.19
Net Income$660 million
Net Margins23.25%
Return on Equity20.72%
Return on Assets17.70%
Miscellaneous
Employees4,444
Outstanding Shares113,290,000
Intuitive Surgical (NASDAQ:ISRG) Frequently Asked Questions
What is Intuitive Surgical's stock symbol?
Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."
When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?
Intuitive Surgical's stock split before market open on Friday, October 6th 2017. The 3-1 split was announced on Friday, August 11th 2017. The newly issued shares were payable to shareholders after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.
How were Intuitive Surgical's earnings last quarter?
Intuitive Surgical, Inc. (NASDAQ:ISRG) posted its quarterly earnings data on Tuesday, April, 17th. The medical equipment provider reported $2.44 EPS for the quarter, beating analysts' consensus estimates of $2.07 by $0.37. The medical equipment provider earned $848 million during the quarter, compared to the consensus estimate of $773.20 million. Intuitive Surgical had a return on equity of 20.72% and a net margin of 23.25%. The company's quarterly revenue was up 25.8% compared to the same quarter last year. During the same period last year, the company earned $5.09 EPS. View Intuitive Surgical's Earnings History.
When is Intuitive Surgical's next earnings date?
What price target have analysts set for ISRG?
15 equities research analysts have issued 1 year price targets for Intuitive Surgical's shares. Their forecasts range from $350.01 to $535.00. On average, they anticipate Intuitive Surgical's share price to reach $453.2395 in the next twelve months. View Analyst Ratings for Intuitive Surgical.
What are Wall Street analysts saying about Intuitive Surgical stock?
Here are some recent quotes from research analysts about Intuitive Surgical stock:
- 1. According to Zacks Investment Research, "Intuitive Surgical outperformed its industry in a year’s time. The company’s flagship da Vinci procedures recorded solid growth and holds promise for the quarters ahead. Moreover, recently, da Vinci Surgical System has successfully cured inguinal hernia. Intuitive Surgical also saw solid expansion outside the United States in the recent past. A suite of regulatory approvals buoys optimism. Solid growth in prostatectomy procedure volumes lent Intuitive Surgical a competitive edge in the broader prostate surgery market. However, the company expects U.S. sales to decline in the quarters ahead, which raises concern. Furthermore, looming foreign exchange volatility also adds to the woes. Intense competition in niche space and long sale and purchase order cycles of da Vinci unit has been currently plaguing the company." (6/19/2018)
- 2. Cantor Fitzgerald analysts commented, "Top-line results in-line with prelim results; EPS beat. ISRG reported 4Q top-line results consistent with its pre-announcement, including revenue of $892MM (+18%), and procedure growth of 16%. Adj. 4Q EPS was $2.54, beating FactSet consensus by $0.30 on higher-than-expected revenue, better- than-expected margins and a lower tax rate." (1/26/2018)
Who are some of Intuitive Surgical's key competitors?
Some companies that are related to Intuitive Surgical include Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Halyard Health (HYH), Wright Medical Group (WMGI), Invacare (IVC), Consort Medical (CSRMY), Sientra (SIEN) and RTI Surgical (RTIX).
Who are Intuitive Surgical's key executives?
Intuitive Surgical's management team includes the folowing people:
- Dr. Gary S. Guthart, CEO, Pres & Director (Age 52)
- Mr. Marshall L. Mohr, Sr. VP & CFO (Age 62)
- Mr. Salvatore J. Brogna, Exec. VP & COO (Age 63)
- Mr. David J. Rosa, Exec. VP & Chief Commercial Officer (Age 50)
- Dr. Myriam J. Curet McAdams, Exec. VP & Chief Medical Officer (Age 61)
Has Intuitive Surgical been receiving favorable news coverage?
News headlines about ISRG stock have trended somewhat positive recently, according to Accern Sentiment. Accern ranks the sentiment of media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intuitive Surgical earned a daily sentiment score of 0.09 on Accern's scale. They also gave headlines about the medical equipment provider an impact score of 46.40 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are Intuitive Surgical's major shareholders?
Intuitive Surgical's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.07%), Baillie Gifford & Co. (2.69%), Edgewood Management LLC (2.12%), American Century Companies Inc. (1.23%), Northern Trust Corp (1.20%) and Franklin Resources Inc. (0.65%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.
Which major investors are selling Intuitive Surgical stock?
ISRG stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., Envestnet Asset Management Inc., Columbus Circle Investors, Swiss National Bank, Stevens Capital Management LP, American Century Companies Inc., Teacher Retirement System of Texas and California Public Employees Retirement System. Company insiders that have sold Intuitive Surgical company stock in the last year include Alan J Levy, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.
Which major investors are buying Intuitive Surgical stock?
ISRG stock was purchased by a variety of institutional investors in the last quarter, including Summit Trail Advisors LLC, Global X Management Co. LLC, Carmignac Gestion, Old Mutual Global Investors UK Ltd., Edgewood Management LLC, Lord Abbett & CO. LLC, ING Groep NV and Franklin Resources Inc.. View Insider Buying and Selling for Intuitive Surgical.
How do I buy shares of Intuitive Surgical?
Shares of ISRG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Intuitive Surgical's stock price today?
One share of ISRG stock can currently be purchased for approximately $487.45.
How big of a company is Intuitive Surgical?
Intuitive Surgical has a market capitalization of $55.59 billion and generates $3.13 billion in revenue each year. The medical equipment provider earns $660 million in net income (profit) each year or $7.19 on an earnings per share basis. Intuitive Surgical employs 4,444 workers across the globe.
How can I contact Intuitive Surgical?
Intuitive Surgical's mailing address is 1020 KIFER ROAD, SUNNYVALE CA, 94086. The medical equipment provider can be reached via phone at 408-523-2100 or via email at [email protected]
MarketBeat Community Rating for Intuitive Surgical (ISRG)
MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe ISRG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISRG will underperform the S&P 500 over the long term. You may vote once every thirty days.
